<p>Groups of BALB/c mice (n = 10 per group) were vaccinated once, twice or three times by intramuscular injection of plasmids P1, P2, P3 at day 0, 28, and 56. Immunization with vector plasmid pcDNA3.1 was performed as control at day 0. Box-and-whisker plots depict the magnitude of responses in each group for each time point (<i>P</i> value was ≤ 0.05). Levels of cytokine-producing T-lymphocytes are depicted on the <i>y</i> axis. Individual groups of animals are depicted on the <i>x</i> axis.</p
<p>Splenocytes from <i>Mtb</i>-infected or uninfected mice, which were immunized and boosted with Mu...
<p>(<b>A</b>) Vaccination schedule used. (<b>B</b>) Cumulative IFN-γ ELISPOT CD8<sup>+</sup> and CD4...
PBMCs were collected from individual animals at week 10 (two weeks post MVA) and at peak response ti...
<p>(A) Magnitude of the vaccine-specific CD4 or CD8 T cell response. The HIV-specific CD4 or CD8 T c...
<p>Balb/c mice (5–6/group) were immunized with 1×10<sup>8</sup> pfu of Ad vector (Ad-CMV-gagopt, Ad-...
<p>Spleens and blood were collected 12 days after the last vaccination. Splenocytes were stimulated ...
<p>Immune recognition of the peptides representing CD4<sup>+</sup> and CD8<sup>+</sup> epitopes of P...
<p>Mice were injected i.m. on days 1 and 21 with 50 µg of the indicated pITR plasmids encoding mouse...
<p>One week after the second and final immunization splenocytes were analyzed for intracellular cyto...
<p>Cellular immune responses were measured using two different assays: (i) Dextramer analysis of ant...
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>Two weeks after the last immunization with HIVBr27 or empty pVAX1, pooled spleen cells from 6 BAL...
<p>(A) Magnitude of the vaccine-specific CD4 or CD8 T cell responses. The HIV-specific CD4 or CD8 T ...
<p><b>A)</b> PBMCs isolated from blood samples taken at the indicated weeks post-immunization (PI) w...
<p>Two weeks after the last immunization with HIVBr27 or empty pVAX1, pooled spleen cells from 6 BAL...
<p>Splenocytes from <i>Mtb</i>-infected or uninfected mice, which were immunized and boosted with Mu...
<p>(<b>A</b>) Vaccination schedule used. (<b>B</b>) Cumulative IFN-γ ELISPOT CD8<sup>+</sup> and CD4...
PBMCs were collected from individual animals at week 10 (two weeks post MVA) and at peak response ti...
<p>(A) Magnitude of the vaccine-specific CD4 or CD8 T cell response. The HIV-specific CD4 or CD8 T c...
<p>Balb/c mice (5–6/group) were immunized with 1×10<sup>8</sup> pfu of Ad vector (Ad-CMV-gagopt, Ad-...
<p>Spleens and blood were collected 12 days after the last vaccination. Splenocytes were stimulated ...
<p>Immune recognition of the peptides representing CD4<sup>+</sup> and CD8<sup>+</sup> epitopes of P...
<p>Mice were injected i.m. on days 1 and 21 with 50 µg of the indicated pITR plasmids encoding mouse...
<p>One week after the second and final immunization splenocytes were analyzed for intracellular cyto...
<p>Cellular immune responses were measured using two different assays: (i) Dextramer analysis of ant...
<p>(<b>A</b>) Description of the different vectors employed in the DNA/MVA immunization schemes appl...
<p>Two weeks after the last immunization with HIVBr27 or empty pVAX1, pooled spleen cells from 6 BAL...
<p>(A) Magnitude of the vaccine-specific CD4 or CD8 T cell responses. The HIV-specific CD4 or CD8 T ...
<p><b>A)</b> PBMCs isolated from blood samples taken at the indicated weeks post-immunization (PI) w...
<p>Two weeks after the last immunization with HIVBr27 or empty pVAX1, pooled spleen cells from 6 BAL...
<p>Splenocytes from <i>Mtb</i>-infected or uninfected mice, which were immunized and boosted with Mu...
<p>(<b>A</b>) Vaccination schedule used. (<b>B</b>) Cumulative IFN-γ ELISPOT CD8<sup>+</sup> and CD4...
PBMCs were collected from individual animals at week 10 (two weeks post MVA) and at peak response ti...